These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35353966)

  • 1. Added Benefit of Covid-19 Vaccination after Previous Infection.
    Klein NP
    N Engl J Med; 2022 Mar; 386(13):1278-1279. PubMed ID: 35353966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    Larkin H
    JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 infection confers greater immunity than shots.
    Wadman M
    Science; 2021 Sep; 373(6559):1067-1068. PubMed ID: 34516858
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid-19 vaccination: evidence of waning immunity is overstated.
    Scott J; Richterman A; Cevik M
    BMJ; 2021 Sep; 374():n2320. PubMed ID: 34556464
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

  • 7. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
    Dal-Ré R; Orenstein W; Caplan AL
    Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
    [No Abstract]   [Full Text] [Related]  

  • 9. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.
    Krsak M; Harry BL; Palmer BE; Franco-Paredes C
    Viral Immunol; 2021 Oct; 34(8):504-509. PubMed ID: 34227891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
    Priyanka ; Choudhary OP; Singh I
    Travel Med Infect Dis; 2021; 39():101911. PubMed ID: 33186686
    [No Abstract]   [Full Text] [Related]  

  • 11. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
    Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
    Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Appraisal of the Current Scenario in Vaccine Research for COVID-19.
    Chong WC; Chellappan DK; Shukla SD; Peterson GM; Patel RP; Jha NK; Eri RD; Dua K; Tambuwala MM; Shastri MD
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
    Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ
    Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Vaccination and Previous Infection on Omicron Infections in Children.
    Lin DY; Gu Y; Xu Y; Zeng D; Wheeler B; Young H; Sunny SK; Moore Z
    N Engl J Med; 2022 Sep; 387(12):1141-1143. PubMed ID: 36069811
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG vaccine: a hope to control COVID-19 pandemic amid crisis.
    Malik YS; Ansari MI; Ganesh B; Sircar S; Bhat S; Pande T; Vinodhkumar OR; Kumar P; Iqbal Yatoo M; Tiwari R; Touil N; Patel SK; Pathak M; Sharun K; Dhama K
    Hum Vaccin Immunother; 2020 Dec; 16(12):2954-2962. PubMed ID: 32991235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'.
    Dhama K; Singh Malik Y; Rabaan AA; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2020 Dec; 16(12):2888-2890. PubMed ID: 33393853
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of SARS-CoV-2 variants on IBD management.
    Segal JP; Kumar A; Raine T; Lamb CA; Brookes MJ
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):343-344. PubMed ID: 33711289
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
    Parker EPK; Desai S; Marti M; Nohynek H; Kaslow DC; Kochhar S; O'Brien KL; Hombach J; Wilder-Smith A
    Lancet Glob Health; 2022 Mar; 10(3):e326-e328. PubMed ID: 35180408
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 vaccines: modes of immune activation and future challenges.
    Teijaro JR; Farber DL
    Nat Rev Immunol; 2021 Apr; 21(4):195-197. PubMed ID: 33674759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.